Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Cognition in People at Ultra-High Risk for Psychosis

Projekt: Typer af projekterProjekt

Vis graf over relationer
This Ph.D. project is part of ”NEURAPRO-E (North America, EURope, Australia PROdrome) Study: A multicenter RCT of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Symptomatic Patients
at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders”. The purpose is to delineate cognition in patients at high risk (possible “prodromal” patients) and to identify cognitive markers of
functional and clinical outcome. Clinical outcome includes later development of schizophrenia spectrum disorders. In this project, 40 patients classified as prodromal according to several rating criteria (including CAARMS) are included and examined at baseline, and again after 6 months and 12 months. In NEURAPRO-E neurocognition is assessed using BACS (Brief Assessment of Cognition in Schizophrenia), and selected tests from WAIS-III (Wechsler Adult Intelligence Scale). In addition, the project also includes (amongst
others) CANTAB (Cambridge Neuropsychological Test Automated Battery).

ID: 32195290